Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.819 USD | +2.53% | -6.43% | -62.57% |
May. 07 | Transcript : Moleculin Biotech, Inc. - Special Call | |
May. 07 | Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durability with Additional Interim Subject Data | CI |
- Stock Market
- Equities
- MBRX Stock
- News Moleculin Biotech, Inc.
- MarketScreener Editorial Features